Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Foundation Healthcare Holdings IPO: The Biggest SGX Healthcare Listing Since IHH — Worth Chasing?

Special Edition: Foundation Healthcare IPO Singapore hasn't seen a healthcare IPO of this size in over a decade. Foundation Healthcare Holdings (" FHH ") is looking to raise up to S$242 million at an offering price of S$0.76 per share , implying a market capitalisation of roughly S$1.0 billion — reportedly the largest healthcare listing on SGX since IHH Healthcare's dual-listing back in 2012. Public offer closes 6 July, 12pm , with trading expected to start on 8 July 2026 . Let's dig into what FHH actually does, why parts of the story are genuinely attractive, where I'd want to be careful, and whether the pricing leaves anything on the table for IPO subscribers. The Business: A Doctor Roll-Up With a Tech Layer FHH is a multi-specialty private healthcare platform built on three verticals: Specialists — 108 full-time medical specialists across 16 specialties and 74 specialist clinics as at 31 March 2026, making...

Eindec Corporation Limited



Eindec Corporation Limited ("Eindec" or the "Company") is offering 35.8m Placement Shares at $0.21 each for a listing on Catalist. The offer will end on 13 Jan 2016 at 12pm and there is no public tranche and i will not spend too much time researching into this Company. The market cap is S$22.6m based on the IPO price.

The Company is a regional clean air environmental and technological solutions group with diversified product lines across different market segments. The Company has an operating history since 1984 with 2 manufacturing facilities in Singapore and Malaysia.

Diversified Product Ranges

The diversified product range is listed below


Financial Highlights


While the prospectus looks promising, the financial statements somewhat painted a different picture. The sales stagnated over the last 3 years with declining profitability. Even the 1H results continued to show declining net profit. Without considering other factors and based purely on the financial results alone, i would have given this Company a miss.

Based on the IPO price of 21 cents, the Company is listing at a historical PER of around 21 divide by 1.27 = 16x. This is pretty expensive and over-valued in the light of declining EPS in 1H 2015. In 2014, the 1H results is actually better than 2H, so even where i gave it the benefit of doubling 1H 2015 EPS, the valuation is very high at 21 divided by 0.66 = 32x.


Future Business Plans

The Company started to market its own brand of purifiers in China. Given the poor air quality in China, it is a strategy that might have some potential but it is too early to tell. 

What i like about the Company
  • Audited by KPMG, a big 4 auditor
  • Not withstanding the slowing Chinese economy, there could be some potential for China upside given the new parentage. 
Some of my concerns
  • Stagnant revenue and declining profitability
  • Small cap company
  • Ghost of the past in the poorly managed Kyodo Allied. How did it even get re-listed again!!

My Ratings

If there is a public tranche, i would have given it a zero chilli ratings. Given the bloodshed in the markets since Jan 2016, you can get bigger and better managed companies at half the valuation. Use your time to look for something better in the market instead. ^_^

Happy IPOing

Comments

Anonymous said…
First Singapore IPO of the year, debuts on Friday 15 January 2016; closed 21% higher at 25.5 cents from offer price of 21 cents. Around 7.5m shares changed hands.
Mr. IPO said…
Nice debut. Probably the shares are placed out to friends and family. :)